Tru Check Intelli Cancer Detection
When you detect cancer in its early stages, treatment is more effective and the chances of a positive outcome are significantly increased. It also helps prevent the spread of cancer to other parts of the body.
Our TruCheck™ Early Cancer Screening blood test is a thorough check for the existence of cancer in your body, identifying which type of cancer(s) you have, and from which organ they have originated.
Book your appointment
TruCheck Intelli Early Multi-Cancer Screening
Revolutionary early cancer detection—through a single blood test.
Effect Doctors is proud to offer the TruCheck Intelli test, one of the UK’s first publicly available blood tests that screens for Circulating Tumour Cells (CTCs)—early indicators of solid organ cancers. This cutting-edge screening can detect cancer in its earliest, most treatable stages, using just a small sample of blood.
How It Works
The process is simple and non-invasive. Once you book your test, one of our UK-based doctors will schedule a pre-test consultation to review your medical history, assess your suitability, and guide you through the procedure. If the test isn’t right for you, a full refund will be issued.*
After approval, you’ll receive a testing kit to take to your chosen phlebotomy clinic, where your blood sample will be drawn. The sample is then sent to a leading UK laboratory for advanced analysis, with results typically returned in 2–3 weeks.
Why Choose TruCheck Intelli?
-
Groundbreaking technology – the first publicly available test in the UK to identify CTCs with high accuracy.
-
Early detection – spots cancer before symptoms appear, improving treatment outcomes.
-
Precise insights – pinpoints where in the body the cancer originated, helping clinicians target care quickly.
-
Clinically backed – supported by robust clinical trials and used globally.
What It Tests For
TruCheck Intelli screens for a wide range of solid organ cancers, including:
-
Breast
-
Lung
-
Liver
-
Prostate
-
Gastrointestinal
-
Gynaecological
-
Thyroid
-
Melanoma
-
Brain and Central Nervous System
… and many more.
Frequently Asked Questions
Find out moreWhat if my results come back as ‘positive’?
A positive result means that CTCs have been found in your blood. The test results will indicate the location for the select type of cancers with high accuracy, and in other cancers the tissue of origin can be identified with reasonable accuracy. This means we can tell you where the cancer started developing in your body.
With any positive result, a member of the clinical team will call you personally to discuss your results, what they mean and guide you on your next steps which would include a referral. We have an established patient pathway if you get a positive result.
Does a ‘negative’ result mean that I am ‘totally’ cancer free?
A negative result means that at the time of the test there were no detectable cancer cells for the cancers included within the test, circulating in your blood. It does not mean that you will never develop cancer. For any cancers not covered by the test, no inference should be drawn from a negative result.
Are there any restrictions on who can take this test?
We have certain clinical requirements that you must fulfil in order to be eligible to take this test. You will need to complete an online form when you checkout to confirm these and they will be checked during a pre-consultation call with our Doctor.
To take this test you must:
- Be 40 years of age or older. (35 – 40 year olds accepted subject to being deemed high risk, please enquire)
- Not have any symptoms of cancer currently. If you have suspected symptoms, you should visit your GP urgently.
- Not have any clinical or radiological suspicion of cancer currently.
- Have not ever been diagnosed with any type of cancer.
- Have not previously had any treatment for any type of cancer.
- Not have a blood transfusion within 72 hours of your blood draw appointment.
*Please ensure you carefully review the eligibility criteria mentioned above before booking the test, as failure to meet the criteria or any subsequent changes may result in the test being declined during the pre-consultation, and a refund will be issued minus the cost of the GP’s pre-consultation.
How frequently should I take this test?
As this early cancer screening test is non-invasive, there is no disadvantage to frequent testing. However, we advise that this test should be performed every 12 months in the case of each negative result, perhaps as part of an annual complete health check process.
Related Products
